Mark Hew

7.5k total citations
131 papers, 3.3k citations indexed

About

Mark Hew is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Mark Hew has authored 131 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 84 papers in Physiology and 25 papers in Immunology and Allergy. Recurrent topics in Mark Hew's work include Asthma and respiratory diseases (69 papers), Respiratory and Cough-Related Research (52 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers). Mark Hew is often cited by papers focused on Asthma and respiratory diseases (69 papers), Respiratory and Cough-Related Research (52 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers). Mark Hew collaborates with scholars based in Australia, United Kingdom and Singapore. Mark Hew's co-authors include Kian Fan Chung, Tunn Ren Tay, Pankaj Bhavsar, Alfons Torregó, Nadia Khorasani, Robyn E. O’Hehir, Eli Dabscheck, Ryan Hoy, Daniel Steinfort and Fiona Hore‐Lacy and has published in prestigious journals such as JAMA, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Mark Hew

124 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Hew Australia 31 2.1k 1.9k 468 455 305 131 3.3k
Mauro Maniscalco Italy 33 1.4k 0.7× 1.4k 0.7× 321 0.7× 165 0.4× 457 1.5× 186 3.2k
Alan R. Leff United States 35 1.5k 0.7× 1.5k 0.8× 442 0.9× 796 1.7× 1.1k 3.5× 120 4.0k
Mina Gaga Greece 39 2.8k 1.3× 2.1k 1.1× 1.6k 3.5× 949 2.1× 313 1.0× 120 5.1k
Enrico Heffler Italy 37 2.9k 1.4× 1.8k 0.9× 1.8k 3.8× 801 1.8× 258 0.8× 248 5.1k
Alessandro Vatrella Italy 41 2.4k 1.1× 1.9k 1.0× 800 1.7× 822 1.8× 618 2.0× 170 4.6k
Celeste Porsbjerg Denmark 32 2.9k 1.4× 2.1k 1.1× 775 1.7× 603 1.3× 246 0.8× 207 3.8k
Pierre‐Olivier Girodet France 25 1.2k 0.5× 1.3k 0.7× 182 0.4× 483 1.1× 482 1.6× 75 2.6k
Kazuto Matsunaga Japan 31 1.4k 0.7× 1.5k 0.8× 270 0.6× 444 1.0× 391 1.3× 149 2.7k
You Sook Cho South Korea 30 1.2k 0.6× 1.0k 0.5× 285 0.6× 613 1.3× 592 1.9× 157 3.1k
Njira Lugogo United States 28 2.5k 1.2× 2.1k 1.1× 458 1.0× 735 1.6× 345 1.1× 160 3.9k

Countries citing papers authored by Mark Hew

Since Specialization
Citations

This map shows the geographic impact of Mark Hew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hew more than expected).

Fields of papers citing papers by Mark Hew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hew. The network helps show where Mark Hew may publish in the future.

Co-authorship network of co-authors of Mark Hew

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hew. A scholar is included among the top collaborators of Mark Hew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hew. Mark Hew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Arwel W., Vanessa M. McDonald, Rebecca F. McLoughlin, et al.. (2025). Experiences of Oral Corticosteroid Use and Adverse Effects: A National Cross-Sectional Survey of People with Asthma. Patient Preference and Adherence. Volume 19. 75–85.
2.
Denton, Eve, Brigitte M. Borg, Janine Mahoney, et al.. (2024). Investigation of exertional dyspnoea by cardiopulmonary exercise testing with continuous laryngoscopy. Journal of science and medicine in sport. 28(2). 95–100. 1 indexed citations
3.
Varese, Nirupama, Pei M. Aui, Bruce D. Wines, et al.. (2024). Accurate determination of house dust mite sensitization in asthma and allergic rhinitis through cytometric detection of Der p 1 and Der p 2 binding on basophils (CytoBas). Journal of Allergy and Clinical Immunology. 153(5). 1282–1291.e10. 5 indexed citations
4.
Hamada, Yuto, Dennis Thomas, Erin S. Harvey, et al.. (2024). Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. European Respiratory Journal. 65(1). 2400782–2400782. 5 indexed citations
5.
Pham, Jonathan, Eve Denton, Joy Lee, et al.. (2023). Trait profiles in difficult‐to‐treat asthma: Clinical impact and response to systematic assessment. Allergy. 78(9). 2418–2427. 9 indexed citations
6.
Leong, Paul, Peter G. Gibson, Anne E. Vertigan, et al.. (2023). Vocal cord dysfunction/inducible laryngeal obstruction—2022 Melbourne Roundtable Report. Respirology. 28(7). 615–626. 15 indexed citations
7.
Voskamp, Astrid, Hannah A. DeBerg, Mark Hew, et al.. (2023). Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy. Allergy. 79(2). 485–498. 14 indexed citations
8.
Kritikos, Vicky, Erin S. Harvey, Sean Stevens, et al.. (2022). Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma. The Journal of Allergy and Clinical Immunology In Practice. 11(3). 885–895.e13. 7 indexed citations
9.
Liu, David, et al.. (2021). Post‐acute care for asthma patients presenting to an Australian hospital network. Internal Medicine Journal. 51(11). 1959–1962. 1 indexed citations
10.
Blakey, John, Li Ping Chung, Vanessa M. McDonald, et al.. (2021). Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand. Respirology. 26(12). 1112–1130. 54 indexed citations
11.
Lee, Joy, Tunn Ren Tay, Brigitte M. Borg, et al.. (2021). Laryngeal hypersensitivity and abnormal cough response during mannitol bronchoprovocation challenge. Respirology. 27(1). 48–55. 3 indexed citations
12.
Price, David, Liam G. Heaney, Mark Hew, et al.. (2019). INTERNATIONAL SEVERE ASTHMA REGISTRY (ISAR): PROTOCOL FOR A GLOBAL REGISTRY. Respirology. 24(S2). 59–59. 1 indexed citations
13.
O’Hehir, Robyn E., et al.. (2019). Hypotensive episodes associated with azithromycin infusion: a potentially fatal adverse drug reaction. Respirology Case Reports. 7(7). e00464–e00464. 3 indexed citations
14.
Chung, Li Ping, John W. Upham, Philip G. Bardin, & Mark Hew. (2019). Rational oral corticosteroid use in adult severe asthma: A narrative review. Respirology. 25(2). 161–172. 61 indexed citations
15.
Steinfort, Daniel, et al.. (2018). Diagnostic chest ultrasound for acute respiratory failure. Respiratory Medicine. 141. 26–36. 24 indexed citations
16.
Eguíluz‐Gracia, Ibon, Tunn Ren Tay, Mark Hew, et al.. (2018). Recent developments and highlights in biomarkers in allergic diseases and asthma. Allergy. 73(12). 2290–2305. 71 indexed citations
17.
Tay, Tunn Ren & Mark Hew. (2017). Comorbid “treatable traits” in difficult asthma: Current evidence and clinical evaluation. Allergy. 73(7). 1369–1382. 115 indexed citations
18.
Dabscheck, Eli, Mark Hew, Louis Irving, & Daniel Steinfort. (2014). Bronchoscopic Training and Practice in Australia and New Zealand Is Inconsistent With Published Society Guidelines. Journal of Bronchology & Interventional Pulmonology. 21(2). 117–122. 7 indexed citations
19.
20.
Comhair, Suzy, Kristin Ricci, Mercedes E. Arroliga, et al.. (2005). Correlation of Systemic Superoxide Dismutase Deficiency to Airflow Obstruction in Asthma. American Journal of Respiratory and Critical Care Medicine. 172(3). 306–313. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauro Maniscalco Breakdown of academic impact, for papers by Alan R. Leff Breakdown of academic impact, for papers by Mina Gaga Breakdown of academic impact, for papers by Enrico Heffler Breakdown of academic impact, for papers by Alessandro Vatrella Breakdown of academic impact, for papers by Celeste Porsbjerg Breakdown of academic impact, for papers by Pierre‐Olivier Girodet Breakdown of academic impact, for papers by Kazuto Matsunaga Breakdown of academic impact, for papers by You Sook Cho Breakdown of academic impact, for papers by Njira Lugogo
Rankless by CCL
2026